Oculis (OCS) News Today $19.20 -0.48 (-2.43%) As of 06/13/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OCS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Q2 Earnings Forecast for Oculis Issued By Leerink PartnrsJune 10, 2025 | americanbankingnews.comLeerink Partnrs Forecasts Oculis' Q2 Earnings (NASDAQ:OCS)Oculis Holding AG (NASDAQ:OCS - Free Report) - Investment analysts at Leerink Partnrs cut their Q2 2025 earnings per share estimates for Oculis in a research note issued on Wednesday, June 4th. Leerink Partnrs analyst M. Goodman now expects that the company will earn ($0.50) per share for the quaJune 9, 2025 | marketbeat.comOculis Publishes Results of 2025 Annual General MeetingJune 5, 2025 | globenewswire.comOculis Publishes Results of 2025 Annual General MeetingJune 5, 2025 | globenewswire.comCitadel Advisors LLC Buys Shares of 22,911 Oculis Holding AG (NASDAQ:OCS)Citadel Advisors LLC acquired a new stake in shares of Oculis Holding AG (NASDAQ:OCS - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 22,911 shares of the company's stock, valued at apprJune 4, 2025 | marketbeat.comOculis Publishes Notifications of Transactions by Persons Discharging Managerial ResponsibilitiesJune 3, 2025 | globenewswire.comOculis to Participate in Upcoming June Investor ConferencesJune 3, 2025 | markets.businessinsider.comOculis to Participate in Upcoming June Investor ConferencesJune 3, 2025 | globenewswire.comOculis to Participate in Upcoming June Investor ConferencesJune 3, 2025 | globenewswire.comResearch Analysts Set Expectations for Oculis Q2 EarningsOculis Holding AG (NASDAQ:OCS - Free Report) - Stock analysts at HC Wainwright dropped their Q2 2025 EPS estimates for Oculis in a research note issued on Monday, May 12th. HC Wainwright analyst Y. Chen now forecasts that the company will post earnings of ($0.47) per share for the quarter, down fMay 16, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for Oculis Q1 Earnings?Oculis Holding AG (NASDAQ:OCS - Free Report) - Investment analysts at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for shares of Oculis in a report issued on Monday, May 12th. HC Wainwright analyst Y. Chen expects that the company will earn ($0.46) per share for the quartMay 15, 2025 | marketbeat.comOculis (NASDAQ:OCS) Sees Strong Trading Volume Following Analyst UpgradeOculis (NASDAQ:OCS) Sees Unusually-High Trading Volume After Analyst UpgradeMay 14, 2025 | marketbeat.comChardan Capital Forecasts Strong Price Appreciation for Oculis (NASDAQ:OCS) StockChardan Capital lifted their price target on Oculis from $28.00 to $33.00 and gave the stock a "buy" rating in a research report on Friday.May 11, 2025 | marketbeat.comOculis Holding AG: Oculis Reports Q1 Financial Results and Provides Company UpdateMay 11, 2025 | finanznachrichten.deOculis Publishes Invitation to the Annual General MeetingMay 9, 2025 | globenewswire.comOculis Publishes Invitation to the Annual General MeetingMay 9, 2025 | globenewswire.comOculis (OCS) Expected to Announce Earnings on WednesdayOculis (NASDAQ:OCS) will be releasing its Q1 2025 earnings before the market opens on Wednesday, May 14. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-14-oculis-holding-ag-stock/)May 9, 2025 | marketbeat.comOculis Reports Q1 Financial Results and Provides Company UpdateMay 8, 2025 | globenewswire.comOculis Reports Q1 2025 Financial Results and Provides Company UpdateMay 8, 2025 | globenewswire.comOculis to Present at Upcoming May Investor ConferencesMay 7, 2025 | globenewswire.comOculis to Present at Upcoming May Investor ConferencesMay 7, 2025 | globenewswire.comOculis (NASDAQ:OCS) Sees Large Volume Increase - Still a Buy?Oculis (NASDAQ:OCS) Sees Strong Trading Volume - Should You Buy?May 5, 2025 | marketbeat.comOculis to Present its Innovative Late-Stage Pipeline Candidates at Upcoming Ophthalmology ConferencesMay 1, 2025 | globenewswire.comOculis to Present its Innovative Late-Stage Pipeline Candidates at Upcoming Ophthalmology ConferencesMay 1, 2025 | globenewswire.comOculis (NASDAQ:OCS) Stock Price Up 3.7% - Here's WhyOculis (NASDAQ:OCS) Stock Price Up 3.7% - Time to Buy?April 30, 2025 | marketbeat.comOculis Holding AG (NASDAQ:OCS) Sees Large Decrease in Short InterestOculis Holding AG (NASDAQ:OCS - Get Free Report) was the recipient of a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 22,600 shares, a decline of 55.4% from the March 31st total of 50,700 shares. Based on an average daily trading volume, of 52,700 shares, the days-to-cover ratio is presently 0.4 days. Approximately 0.1% of the company's shares are short sold.April 30, 2025 | marketbeat.comOculis (NASDAQ:OCS) Sees Strong Trading Volume - Time to Buy?Oculis (NASDAQ:OCS) Sees Large Volume Increase - Here's WhyApril 27, 2025 | marketbeat.comOculis Updates Share CapitalApril 25, 2025 | globenewswire.comOculis (NASDAQ:OCS) Stock Price Down 2.5% - What's Next?Oculis (NASDAQ:OCS) Shares Down 2.5% - What's Next?April 24, 2025 | marketbeat.comOculis (NASDAQ:OCS) Shares Gap Up Following Analyst UpgradeOculis (NASDAQ:OCS) Shares Gap Up After Analyst UpgradeApril 19, 2025 | marketbeat.comHC Wainwright Issues Positive Forecast for Oculis (NASDAQ:OCS) Stock PriceHC Wainwright boosted their price target on Oculis from $29.00 to $32.00 and gave the company a "buy" rating in a research note on Thursday.April 19, 2025 | marketbeat.comOculis' (OCS) Buy Rating Reaffirmed at Chardan CapitalChardan Capital reaffirmed a "buy" rating and issued a $28.00 target price on shares of Oculis in a report on Thursday.April 19, 2025 | marketbeat.comOculis Holding (OCS) Receives a Buy from Bank of America SecuritiesApril 17, 2025 | markets.businessinsider.comOculis and EURETINA Announce the 2025 Ramin Tadayoni AwardApril 17, 2025 | globenewswire.comOculis Holding AG Unveils Key Clinical Updates and Future Outlook at R&D DayApril 15, 2025 | tipranks.comOculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline AssetsApril 15, 2025 | globenewswire.comOculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline AssetsApril 15, 2025 | globenewswire.comOculis completes enrollment for pivotal DME treatment trialsApril 12, 2025 | uk.investing.comOculis completes enrolment in trials for diabetic macular oedema eye dropsApril 11, 2025 | finance.yahoo.comOculis Holding AG: Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular EdemaApril 11, 2025 | finanznachrichten.deOculis (NASDAQ:OCS) Stock Price Up 7.4% - Here's What HappenedOculis (NASDAQ:OCS) Shares Up 7.4% - Here's What HappenedApril 10, 2025 | marketbeat.comOculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular EdemaApril 10, 2025 | globenewswire.comOculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular EdemaApril 10, 2025 | globenewswire.comOculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular EdemaApril 10, 2025 | globenewswire.comOculis Publishes Notifications of Transactions by Persons Discharging Managerial ResponsibilitiesApril 9, 2025 | globenewswire.comOculis Publishes Notifications of Transactions by Persons Discharging Managerial ResponsibilitiesApril 9, 2025 | globenewswire.comOculis (NASDAQ:OCS) Shares Down 9.1% - Here's WhyOculis (NASDAQ:OCS) Trading Down 9.1% - Time to Sell?April 9, 2025 | marketbeat.comOculis (NASDAQ:OCS) Shares Gap Down - Here's WhyOculis (NASDAQ:OCS) Shares Gap Down - Here's WhyApril 6, 2025 | marketbeat.comA First Look At Oculis Holding AG: Revenues Still Several Years AwayApril 3, 2025 | seekingalpha.comOculis to Host In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and BeyondApril 1, 2025 | globenewswire.com Get Oculis News Delivered to You Automatically Sign up to receive the latest news and ratings for OCS and its competitors with MarketBeat's FREE daily newsletter. Email Address OCS Media Mentions By Week OCS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OCS News Sentiment▼-0.110.88▲Average Medical News Sentiment OCS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OCS Articles This Week▼73▲OCS Articles Average Week Get Oculis News Delivered to You Automatically Sign up to receive the latest news and ratings for OCS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PTGX News Today SRRK News Today ALVO News Today MTSR News Today CPRX News Today VKTX News Today KYMR News Today CRNX News Today MLTX News Today MOR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OCS) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oculis Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Oculis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
